On eve of Brexit, Britain faces critical test to defend drug trial crown

LONDON (Reuters) – It’s 2023. Britain’s brightest and best drug researchers are packing their bags as clinical trials start to dwindle, leaving a nation renowned as a global leader in pharmaceutical development to face a future in the slow lane. This is a wors... More »